Core Insights - Ocumetics Technology Corp. has initiated patient recruitment for its first-in-human study of the Ocumetics accommodating intraocular lens, with recruitment expected to be completed in approximately 7 days [1][2]. Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patients' quality of life [4]. - The company is dedicated to transforming the field of ophthalmology through innovative research and development of intraocular lenses and other vision-enhancing technologies [4]. Product Development - The Ocumetics Lens is designed to change its power in response to the brain's attempts to visualize items at varying distances, unlike traditional monofocal and multifocal intraocular lenses [2]. - The lens aims to provide clear vision at all distances without the need for glasses or contact lenses, potentially eliminating the need for corrective lenses altogether [5]. Clinical Study Details - The first-in-human clinical study will primarily assess the safety of the Ocumetics Lens and secondarily evaluate surgical technique, distance acuity, and any accommodative effects [2]. - Implantations will commence after the completion of patient recruitment, final site inspection, and surgeon training [3]. - Results from this clinical study will be crucial for obtaining regulatory approval for larger future studies and for bringing the Ocumetics Lens to market [3].